Metraipolis › archive › dc_0b52cc2883ad

Mechanisms and management strategies for exacerbated bone loss following denosumab discontinuation — Europe PMC PMID:42568547

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42568547
DOI
10.3389/fragi.2026.1886424
License (as archived)
solo-consultazione
Archived
2026-10-17T20:00:03.255Z
SHA-256 of the archived text
2d3f5241d4fa60fa0adb9ef49a95ba5f1d9eba810bc491a2e30733b794fdf9e1
Stable URL of this page
https://metraipolis.com/documento/dc_0b52cc2883ad

How to cite

Mechanisms and management strategies for exacerbated bone loss following denosumab discontinuation — Europe PMC PMID:42568547 — Europe PMC (en), https://europepmc.org/article/MED/42568547 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0b52cc2883ad (Metraipolis archive dc_0b52cc2883ad, sha256 2d3f5241d4fa60fa0adb9ef49a95ba5f1d9eba810bc491a2e30733b794fdf9e1)
BibTeX
@misc{dc0b52cc2883ad,
  title = {Mechanisms and management strategies for exacerbated bone loss following denosumab discontinuation — Europe PMC PMID:42568547},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42568547},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0b52cc2883ad; sha256 2d3f5241d4fa60fa0adb9ef49a95ba5f1d9eba810bc491a2e30733b794fdf9e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42568547. Agents can read the archived copy with the MCP tool read_document.